NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study...
-
Upload
clement-chambers -
Category
Documents
-
view
222 -
download
5
Transcript of NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study...
![Page 1: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/1.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
Platelets for Neonatal Transfusion Study 2 (PlaNeT-2):
A randomised controlled trial of platelet transfusion thresholds
![Page 2: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/2.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
Current national transfusion guidance based on
consensus rather than evidence British Committee for Standards in Haematology (2004)
United Kingdom Blood Services (2007)
Survey in the UK showed wide variation in platelet
transfusion practice Chaudhary and Clarke (2008)
Neonatal Thrombocytopenia: Current Practice
![Page 3: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/3.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
Platelets for Neonatal Transfusion - Study 2
PlaNeT-2
![Page 4: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/4.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
PlaNeT-2: Study design (I)
Two-stage, randomised, parallel group, superiority trial.
Aim: to compare two different platelet count thresholds for
prophylactic platelet transfusion to preterm neonates.
Primary Outcome:• Proportion of patients who either die or experience a major
bleed up to and including study day 28.
![Page 5: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/5.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
PlaNeT-2: Study design (II)
Secondary Outcomes:• Proportion of neonates surviving to home following a
major bleed• Mortality prior to day 28• Major bleeds by day 28 • Platelets transfused to study day 28• Length of hospital stay• Transfusion-related adverse events • Neuro-developmental outcome
![Page 6: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/6.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
PlaNeT-2: Choosing platelet thresholds
Last RCT done by Andrew et al (1993) assessed
50-150x109/L vs. >150x109/L
PlaNeT-1 (2009):
• Most transfusions given at platelets 10–50x109/L.
• 50th and 90th centile pre-transfusion platelet counts
27 and 48x109/L.
• 42% transfusions <25x109/L and 92% <50x109/L
![Page 7: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/7.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
PlaNeT-2: Platelet thresholds
• Arm A Standard: transfuse platelets at <25x109/L
(330 neonates)
• Arm B Intervention: transfuse platelets at <50x109/L
(330 neonates)
Dose: 15 ml/kg
![Page 8: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/8.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
PlaNeT-2: Additional platelet transfusions
May be considered under the following circumstances:
• Therapeutically to treat moderate, major or severe bleeding but not for minor bleeding.
• Prior to planned invasive procedures as below only – Suprapubic aspiration
– Lumbar puncture
– Major surgery where haemostasis may be critical to outcome.
![Page 9: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/9.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
Grade 1 – Minor HaemorrhageAny bleed from the
skin, umbilical cord, skin around stoma, surgical scar, mucosa. Any pink frothy or old bleed from the ET tube. H1 haemorrhage on cranial US (Germinal Layer Haemorrhage, GLH)
Grade 2 – Moderate HaemorrhageAny frank bleed from
• the stoma • macroscopic haematuria, • IVH (H2 or H3) without dilatation (V0), • Acute fresh bleed through ETT without ventilatory changes
Grade 3 – Major Haemorrhage any:• Frank Rectal • Acute fresh bleed through ETT with ventilatory change. • Intracranial bleed An intracranial bleed is defined as a major bleed if any of the following apply: Neurosurgical
intervention is required; Scans show a midline shift; Clinical signs and symptoms of neurolgical deficit with significant derangement of laboratory investigations
• Major IVH is defined as H2 or H3 with ventricular dilatation (V1); H1, H2, H3 with parenchymal involvement (P3) ; Any evolution of intracranial haemorrhage to H2V1, H3V1, or (H1, H2, H3) with parenchymal involvement (P3)
Grade 4 – Severe Haemorrhage• Shock defined as life threatening major bleed associated with hypotension, hyopovolaemia or any other
haemodynamic instability and/or bleeding requiring volume boluses, red cell transfusion in the same 24 hours, fatal major bleeding
Modified WHO Bleeding Assessment Score
![Page 10: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/10.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
• Admission to a participating NICU (includes postnatal transfers)
• <34 weeks GA at birth
• Platelet count of <50 x109/L
• Cranial ultrasound scan: undertaken <6 hours before randomisation to exclude recent major IVH
PlaNeT-2: Inclusion criteria
![Page 11: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/11.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
• Major/life-threatening congenital malformations
• Recent major haemorrhage within the last 72 hours
• All fetal intracranial haemorrhages
• Known immune thrombocytopenia
• Neonates unlikely to survive
• Neonates not given parenteral vitamin K
PlaNeT-2: Exclusion criteria
![Page 12: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/12.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
When platelets <100x109/L
When platelets <50x109/L
PlaNeT-2: Consent
Document on PlaNeT-2 log book
![Page 13: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/13.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
PlaNeT-2: Randomisation
When the consent is signed and platelets <50x109/L:
Pre-randomisation
Platelet transfusion information
(FA)
Pre-randomisation
form (F1)
Eligibility for randomisation
(F2)
Current medical
conditions & previous major
bleeds (F3)
Randomisation (F4)
![Page 14: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/14.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
FA – Platelet transfusion information
![Page 15: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/15.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F1 – Pre-randomisation
![Page 16: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/16.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F2 – Eligibility for randomisation
![Page 17: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/17.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F3 – Current medical conditionsAnd previous major bleeds
![Page 18: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/18.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F4 – Randomisation
![Page 19: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/19.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
PlaNeT-2: Data collection (I)
![Page 20: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/20.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F5 – Bleeding Assessment Tool (BAT)
![Page 21: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/21.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F6 – Daily Platelet Count
![Page 22: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/22.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F7 – Weekly Data Collection
![Page 23: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/23.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
PlaNeT-2: Data collection (II)
F9
F13
F10
F14
F15
F8
![Page 24: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/24.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F8 – Platelet Transfusion Data
![Page 25: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/25.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
• Necrotising enterocolitis ≥ Stage 2 defined as per Bells Criteria (Bell et al,1978)
• Sepsis: culture positive sepsis or culture negative sepsis where a course of at least 5 days of antibiotics is to be administered for proven or clinically-suspected sepsis.
• All episodes of NEC and sepsis must be recorded on the adverse event form
• A listing of adverse events will be reported six monthly to the Independent Data Monitoring Committee.
PlaNeT-2: NEC/Sepsis form
![Page 26: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/26.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F9 – NEC/Sepsis form
![Page 27: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/27.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F10 – Discontinuation of Treatment Allocation
![Page 28: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/28.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
• All new major bleeding events will be reported to the CSU without disclosing allocation arm.
• Each report will be forwarded to the Independent Data Monitoring Committee for review as soon as it is received at the CSU.
• In cases of uncertainty the local team may contact one of the CIs or neonatal medical experts.
MAJOR BLEED FORMWithin one working day of becoming aware of an Major Bleed, please fax a completed Major Bleed form to the NHSBT/MRC
CSUFax: 01223 588136
PlaNeT-2: Major/Severe bleed form
![Page 29: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/29.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F13 – Major/Severe Bleed
![Page 30: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/30.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit SAE NOTIFICATION
Within one working day of becoming aware of an SAE, please fax a completed SAE form to the NHSBT/MRC CSU
Fax: 01223 588136
• in death• is life-threatening • requires hospitalisation or prolongation of existing
hospitalisation (including readmission within 28 study days if discharged home earlier)
• there is a likelihood of persistent or significant disability or incapacity
A SAE is an adverse event that results:
PlaNeT-2: Serious Adverse Event (SAE)
![Page 31: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/31.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F14 – Serious Adverse Event
![Page 32: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/32.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
Data collected on serious transfusion related adverse reactions/events will be based on current definitions used by hospitals reporting to UK national haemovigilance reporting schemes (SHOT and MHRA).
These definitions cover the following: Incorrect blood component transfused Acute transfusion reactions Transfusion Related Acute Lung Injury (TRALI) Transfusion transmitted infections, including bacterial transmission Transfusion Associated Circulatory Overload (TACO)
PlaNeT-2: Serious platelet transfusion related adverse event
![Page 33: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/33.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F15 – Serious platelet transfusion related adverse event
![Page 34: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/34.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
PlaNeT-2: End of study
Data collection will cease when the baby is 38 weeks corrected gestational age or time of discharge home
Cranial Ultrasound at End of Study (F11)
End of Study (F12)
![Page 35: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/35.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F11 – Cranial USS at the end of study
![Page 36: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/36.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
F12 – End of study
![Page 37: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/37.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
• Inform the local PlaNeT-2 team if neonate transferred out
of recruiting unit
• Keep all the forms, do not send them with the patient
• If a cranial USS has no been done in the last 7 days,
please perform one before the baby leaves.
PlaNeT-2: Transfer out of recruiting unit
![Page 38: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/38.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
PlaNeT-2: Two years follow up
Thames Regional Perinatal Outcome Group/ Standard Electronic Neonatal Database/ National Neonatal Audit Programme (TRPG/SEND/NNAP) 2- year corrected age outcome form
![Page 39: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/39.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
• Black ink
• For platelet count use the date and time the sample is received in
the lab
• Do not leave blank fields, enter leading zeros
• Any data incorrectly recorded must be crossed through with a single
line and the correct value documented by the side. All corrections
must be initialled and dated by the individual making the changes
PlaNeT-2: Data Quality
![Page 40: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/40.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit
• Check what you need to score from the CRFs
• Follow the Unit’s guidelines • Good quality shot of the right view
• Ask for a second opinion to a senior staff if you need
PlaNeT-2 is a trial based on these USS so that all scans are reviewed at
local level and overseen nationally.
PlaNeT-2: Data Quality – Cranial USS
![Page 41: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/41.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
• Local queries:
• For general trial queries: contact Karen Willoughby; copy Ana Mora.
• For medical queries regarding transfusions, SAEs, grading major/severe bleeds or transfusion reactions contact Simon Stanworth, Anna Curley or Vidheya Venkatesh.
PlaNeT-2: Communications
www.planet-2.com
![Page 42: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/42.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
Two criteria to put a baby’s sticker in the PlaNeT-2 book
• Baby born at less than 34 weeks GA
• Platelets <100
![Page 43: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/43.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
What is the right documentation of consent?
• Three copies of the consent forms signed.
Original in site file• Complete documentation of parental
discussion in the notes
![Page 44: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/44.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
(Please add here examples of your current
documentation practice)
Our practice documenting…
![Page 45: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/45.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
If the baby is consented and his platelets go up to 52 then 51 and then 50 in next three days, what
should you do?
I should wait. As long as the platelet count is 50
or above, the baby can not be randomised.
![Page 46: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/46.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
Two places where you can find forms
• In the PlaNeT-2 box behind the desk
• Online at www.planet-2.com
![Page 47: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/47.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
Where are the details to access to www.sealedenvelope.com?
In the PlaNeT-2 book
![Page 48: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/48.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
What is wrong with this data collection plan?
![Page 49: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/49.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
So, is this plan right now?
![Page 50: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/50.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
Is this a better plan then?
Completed: 48%
![Page 51: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/51.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
How can you know at glance what form is due to be completed?
Looking at the front of the pack;
each PlaNeT-2 baby has a
form with the due dates.
![Page 52: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/52.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
CRF Game
• You will be given 4 CRF Forms :
• 5 – Find 3 sets of mistakes
• 6 - Which two corrections are right?
• 7 - Can you find the two missing fields?
• 9 – What is missing?
![Page 53: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/53.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
Find the three sets of mistakes
![Page 54: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/54.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
Which two corrections are
right?
![Page 55: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/55.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
Can you find the two missing fields?
![Page 56: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/56.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
![Page 57: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/57.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
The baby is transferred out of the Unit, three things you should do:
• Inform the PlaNeT-2 team• Keep all the PlaNeT-2 forms• A cranial USS if none has been done in
the last 7 days
![Page 58: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/58.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
Where is the PlaNeT-2 box kept?
![Page 59: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/59.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
What should you do if an enrolled baby develops a rectal bleeding?
Inform the PlaNeT-2 team.
(A rectal bleeding is a major bleed that
should be reported as soon as possible)
![Page 60: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/60.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
What should you do if a SAE happens?
• Proceed as Trust protocol indicates for that
situation• Inform the research team as soon as possible
![Page 61: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/61.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
If you are not sure, what two things you should do?
• Ask us!! We are here to support you.
• Check on-line: www.planet-2.com
![Page 62: NHSBT/MRC Clinical Studies Unit NHSBT Clinical Studies Unit Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet.](https://reader038.fdocuments.us/reader038/viewer/2022110210/56649e5e5503460f94b581e3/html5/thumbnails/62.jpg)
NHSBT/MRC Clinical Studies UnitNHSBT Clinical Studies Unit NHSBT Clinical Studies Unit
Thank you!